Company

MAXCYTE, INC. (MXCT)

Standardized SEC financial data for MAXCYTE, INC. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001287098 · NASDAQ · Services-Commercial Physical & Biological Research.

Gross margin

81.2%

Operating margin

-157.1%

Net margin

-135.1%

Revenue growth (YoY)

-14.5%

Return on equity

-26.0%

Free cash flow

-$36.2M

Current ratio

8.30×

EPS (diluted)

$-0.42

Ratios for fiscal year 2025, standardized from SEC filings.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$26.2M	$33.9M	$44.3M	$41.3M	$38.6M	$33.0M
Cost of revenue	$2.8M	$3.6M	$5.1M	$4.7M	$7.1M	$6.2M
Gross profit	$23.4M	$30.2M	$39.2M	$36.5M

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$18.8M	$47.8M	$11.1M	$46.5M	$27.9M	$20.1M
Inventory	$4.3M	$5.2M	$8.6M	$12.2M	$8.9M	$7.5M
Total current assets	$45.3M	$270.4M	$252.3M	$190.2M

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$8.8M	-$10.7M	-$14.8M	-$21.7M	-$27.6M	-$34.4M
Capital expenditures	$2.1M	$3.8M	$18.5M	$3.7M	$1.7M	$1.8M
Free cash flow	-$10.9M	-$14.5M	-$33.3M	-$25.4M

Get MXCT data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/MXCT/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/MXCT/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View MXCT filings on SEC EDGAR →